Compare AU

Compare JZRO vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Janus Henderson Net Zero Transition Active ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Janus Henderson Net Zero Transition Active ETF (JZRO) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

JZRO

DRUG

Popularity

N/A

Low

Pearlers invested

0

59

Median incremental investment

$0

$897.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,990.87

Average age group

N/A

26 - 35


Key Summary

JZRO

DRUG

Strategy

JZRO.AX was created on 2022-03-09 by Janus Henderson. The fund's investment portfolio concentrates primarily on theme equity. The Fund seeks to achieve a total return after fees that exceeds the total return of the Benchmark over rolling 5 year periods.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

Smurfit WestRock PLC (4.58 %)

Cameco Corp (4.34 %)

Pan American Silver Corp (4.29 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Materials (79.50 %)

Utilities (11.16 %)

Energy (11.14 %)

Other (75.97 %)

Communication Services (33.53 %)

Health Care (23.91 %)

Top 3 countries

Canada (41.39 %)

United States (27.57 %)

Australia (7.16 %)

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.85 %

0.57 %


Key Summary

JZRO

DRUG

Issuer

Janus Henderson

BetaShares

Tracking index

S&P Global Natural Resources

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.85 %

0.57 %

Price

$27.60

$8.24

Size

N/A

$189.089 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.99 %

1.89 %

Market

ASX

ASX

First listed date

29/03/2022

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

JZRO

DRUG

Popularity

N/A

Low

Pearlers invested

0

59

Median incremental investment

$0

$897.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,990.87

Average age group

N/A

26 - 35


Pros and Cons

JZRO

DRUG

Pros

  • Higher exposure to AU market

  • Higher distribution yield

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower exposure to AU market

  • Lower distribution yield

JZRO

DRUG

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home